Sientra Inc (SIEN) Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. trimmed its stake in Sientra Inc (NASDAQ:SIEN) by 24.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 329,741 shares of the medical instruments supplier’s stock after selling 107,672 shares during the period. Ameriprise Financial Inc. owned about 1.71% of Sientra worth $5,079,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of Sientra by 11.2% during the 2nd quarter. Vanguard Group Inc. now owns 590,311 shares of the medical instruments supplier’s stock worth $5,737,000 after purchasing an additional 59,546 shares in the last quarter. Cloverdale Capital Management LLC boosted its position in shares of Sientra by 28.9% during the 2nd quarter. Cloverdale Capital Management LLC now owns 492,237 shares of the medical instruments supplier’s stock worth $4,785,000 after purchasing an additional 110,495 shares in the last quarter. Bamco Inc. NY boosted its position in shares of Sientra by 109.3% during the 2nd quarter. Bamco Inc. NY now owns 471,500 shares of the medical instruments supplier’s stock worth $4,583,000 after purchasing an additional 246,183 shares in the last quarter. Schroder Investment Management Group boosted its position in shares of Sientra by 3.5% during the 2nd quarter. Schroder Investment Management Group now owns 432,461 shares of the medical instruments supplier’s stock worth $4,199,000 after purchasing an additional 14,728 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of Sientra by 449.4% during the 2nd quarter. Northern Trust Corp now owns 149,227 shares of the medical instruments supplier’s stock worth $1,451,000 after purchasing an additional 122,066 shares in the last quarter. Institutional investors and hedge funds own 76.63% of the company’s stock.

Shares of Sientra Inc (SIEN) opened at $11.65 on Friday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.87 and a quick ratio of 1.92. The company has a market cap of $225.96, a PE ratio of -4.09 and a beta of -1.47. Sientra Inc has a one year low of $7.20 and a one year high of $16.68.

Sientra (NASDAQ:SIEN) last posted its quarterly earnings data on Tuesday, November 7th. The medical instruments supplier reported ($0.74) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.68) by ($0.06). Sientra had a negative net margin of 169.77% and a negative return on equity of 68.82%. The firm had revenue of $9.80 million during the quarter, compared to analysts’ expectations of $10.54 million. During the same quarter last year, the business posted ($0.55) EPS. The company’s quarterly revenue was up 50.8% on a year-over-year basis. equities research analysts forecast that Sientra Inc will post -3.23 earnings per share for the current year.

A number of research firms have recently issued reports on SIEN. BidaskClub cut shares of Sientra from a “hold” rating to a “sell” rating in a research report on Tuesday, January 9th. Zacks Investment Research raised shares of Sientra from a “sell” rating to a “hold” rating in a research report on Tuesday, January 2nd. ValuEngine raised shares of Sientra from a “sell” rating to a “hold” rating in a research report on Sunday, December 31st. Stifel Nicolaus reaffirmed a “hold” rating and issued a $14.00 price target (up previously from $11.00) on shares of Sientra in a research report on Wednesday, September 27th. Finally, Canaccord Genuity reaffirmed a “buy” rating and issued a $19.00 price target on shares of Sientra in a research report on Friday, January 5th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company. Sientra currently has an average rating of “Hold” and an average target price of $15.00.

COPYRIGHT VIOLATION NOTICE: This article was originally published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.thelincolnianonline.com/2018/01/14/ameriprise-financial-inc-reduces-holdings-in-sientra-inc-sien-updated-updated.html.

Sientra Profile

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Institutional Ownership by Quarter for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply